Publications Supported by the Network
Studies that are supported by the Network receive direct and/or indirect (in-kind) support from the SEAICRN. They utilize the Network's resources that can either be financial, operational, technical, scientific or administrative.
Recent Publications
Wertheim HF., et al., Viral and atypical bacterial aetiologies of infection in hospitalised patients admitted with clinical suspicion of influenza in Thailand, Vietnam and Indonesia. Influenza Other Respir Viruses. 2015 May 16. doi: 10.1111/irv.12326. [Epub ahead of print]
Chea S., et al., Workshop on the use of Intravenous Immunoglobulin in Hand, Foot and Mouth Disease in Southeast Asia, where resources are limited. Emerging Infectious Diseases, 2015. 21(1)
Jittamala, P., et al., Pharmacokinetics of orally administered oseltamivir in healthy obese and nonobese Thai subjects. Antimicrob Agents Chemother, 2014. 58(3): p. 1615-21.
South East Asia Infectious Disease Clinical Research, N., Effect of double dose oseltamivir on clinical and virological outcomes in children and adults admitted to hospital with severe influenza: double blind randomised controlled trial. BMJ, 2013. 346: p. f3039.
Anekthananon, T., et al., Oseltamivir and inhaled zanamivir as influenza prophylaxis in Thai health workers: a randomized, double-blind, placebo-controlled safety trial over 16 weeks. J Antimicrob Chemother, 2013. 68(3): p. 697-707.
Pukrittayakamee, S., et al., An open-label crossover study to evaluate potential pharmacokinetic interactions between oral oseltamivir and intravenous zanamivir in healthy Thai adults. Antimicrob Agents Chemother, 2011. 55(9): p. 4050-7.
Yu, H., et al., Effectiveness of oseltamivir on disease progression and viral RNA shedding in patients with mild pandemic 2009 influenza A H1N1: opportunistic retrospective study of medical charts in China. BMJ, 2010. 341: p. c4779.
Wells, T.N., J.N. Burrows, and J.K. Baird, Targeting the hypnozoite reservoir of Plasmodium vivax: the hidden obstacle to malaria elimination. Trends Parasitol, 2010. 26(3): p. 145-51.
Thanh, T.T., et al., A real-time RT-PCR for detection of clade 1 and 2 H5N1 influenza A virus using locked nucleic acid (LNA) TaqMan probes. Virol J, 2010. 7: p. 46.
Sutanto, I., et al., Evaluation of chloroquine therapy for vivax and falciparum malaria in southern Sumatra, western Indonesia. Malar J, 2010. 9: p. 52.
Stepniewska, K., et al., In vivo parasitological measures of artemisinin susceptibility. J Infect Dis, 2010. 201(4): p. 570-9.
Soepandi, P.Z., et al., Clinical course of avian influenza A(H5N1) in patients at the Persahabatan Hospital, Jakarta, Indonesia, 2005-2008. Chest, 2010. 138(3): p. 665-73.
Nguyen, N.T., et al., The sudden dominance of blaCTX-M harbouring plasmids in Shigella spp. Circulating in Southern Vietnam. PLoS Negl Trop Dis, 2010. 4(6): p. e702.
Ngaosuwankul, N., et al., Influenza A viral loads in respiratory samples collected from patients infected with pandemic H1N1, seasonal H1N1 and H3N2 viruses. Virol J, 2010. 7: p. 75.
Nakamura, K., et al., Possible neuropsychiatric reaction to high-dose oseltamivir during acute 2009 H1N1 influenza A infection. Clin Infect Dis, 2010. 50(7): p. e47-9.
Lee, N., et al., Acute encephalopathy associated with influenza A infection in adults. Emerg Infect Dis, 2010. 16(1): p. 139-42.
Le, Q.M., et al., A community cluster of oseltamivir-resistant cases of 2009 H1N1 influenza. N Engl J Med, 2010. 362(1): p. 86-7.
Lang, T.A., et al., Clinical research in resource-limited settings: enhancing research capacity and working together to make trials less complicated. PLoS Negl Trop Dis, 2010. 4(6): p. e619.
Ison, M.G., et al., End points for testing influenza antiviral treatments for patients at high risk of severe and life-threatening disease. J Infect Dis, 2010. 201(11): p. 1654-62.
Horby, P., et al., Stimulating the development of national Streptococcus suis guidelines in Viet Nam through a strategic research partnership. Bull World Health Organ, 2010. 88(6): p. 458-61.
Horby, P., et al., What is the evidence of a role for host genetics in susceptibility to influenza A/H5N1? Epidemiol Infect, 2010. 138(11): p. 1550-8.
Hietala, S.F., et al., Population pharmacokinetics and pharmacodynamics of artemether and lumefantrine during combination treatment in children with uncomplicated falciparum malaria in Tanzania. Antimicrob Agents Chemother, 2010. 54(11): p. 4780-8.
Hien, T.T., et al., Early pandemic influenza (2009 H1N1) in Ho Chi Minh City, Vietnam: a clinical virological and epidemiological analysis. PLoS Med, 2010. 7(5): p. e1000277.
Blessborn, D., et al., Assay for screening for six antimalarial drugs and one metabolite using dried blood spot sampling, sequential extraction and ion-trap detection. Bioanalysis, 2010. 2(11): p. 1839-47.
Ali, S., et al., Pharmacokinetics of artemether and dihydroartemisinin in healthy Pakistani male volunteers treated with artemether-lumefantrine. Malar J, 2010. 9: p. 275.
Wertheim, H.F., et al., Laboratory capacity building in Asia for infectious disease research: experiences from the South East Asia Infectious Disease Clinical Research Network (SEAICRN). PLoS Med, 2010. 7(4): p. e1000231.
Asih, P.B., et al., Seasonal distribution of anti-malarial drug resistance alleles on the island of Sumba, Indonesia. Malar J, 2009. 8: p. 222.
Previous Network Supported Publications (2006-2009)